Ángel Rivera Novoa

A Novel <b> <i>Ex vivo</i> </b> Model System for Evaluation of Conditionally Replicative Adenoviruses Therapeutic Efficacy and Toxicity

Tyler O. Kirby, Ángel Rivera Novoa, Daniel Rein et al. · Clinical Cancer Research · 2004 · 70 citations

Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo

Zeng B. Zhu, Sharmila Makhija, Baogen Lu et al. · International Journal of Oncology · 2005 · 46 citations

Viral Replication, Survivin Promoter, Immunology +19

Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma

Zeng B. Zhu, Yabing Chen, Sharmila Makhija et al. · International Journal of Oncology · 2006 · 38 citations · Full text

Tumor Biology, Viral Replication, Immunology +12

Reasons for low influenza vaccination coverage among adults in Puerto Rico, influenza season 2013–2014

Carmen Sofia Arriola, Melissa C. Mercado, Brenda Rivera et al. · Vaccine · 2015 · 25 citations · Full text

Vaccination, Preventive Medicine, Puerto Rico +10

Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell lines

T. Michael Numnum, Sharmila Makhija, Baogen Lu et al. · Gynecologic Oncology · 2007 · 18 citations · Full text

Cancer-associated Virus, Rna Interference, Infectivity-enhanced Adenoviral Delivery +8